For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Peanut Flour: Open Label Peanut OIT | This is an open label treatment for subjects who had previously received placebo treatment in a prior peanut OIT study Peanut Flour: open label oral immunotherapy | 0 | None | 0 | 7 | 7 | 7 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Mild allergic reaction-Initial Dose Escalation | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Asthma Exacerbation | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Rhinitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Allergic Conjunctivitis | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Strept Throat | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Sinusitis | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| GERD-not related to dosing | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Mild allergic reaction-Dosing related | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Gastroenteritis | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| influenza | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Otitis Media | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| upper respiratory infection | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Fever | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Eczema Flare | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Vomiting-not associated with dosing | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Nausea-not associated with dosing | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pneumonia | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Wrist Fracture | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Allergic Reaction -not related to dosing | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Otitis Externa | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | None | View |
| Back pain-related to a fall | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Rash-not related to dosing | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Sore Throat | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |